Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
BMC Cancer|April 25, 2015
Frequency and distribution of Notch mutations in tumor cell linesAnders Peter Mutvei, Erik Fredlund, Urban LendahlBiochemical and Biophysical Research Communications|December 25, 2007
Transcriptional adaptation of neuroblastoma cells to hypoxiaErik Fredlund, Marie Ovenberger, Ke Borg, et al.Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaErik Fredlund, Markus Ringnér, John M Maris, et al.Seminars in Cancer Biology|August 4, 2004
Notch signaling in neuroblastomaSven Påhlman, Marie-Thérése Stockhausen, Erik Fredlund, et al.Acta Orthopaedica|November 29, 2016
Are porous tantalum cups superior to conventional reinforcement rings?Anders Brüggemann, Erik Fredlund, Hans Mallmin, et al.Seminars in Cell & Developmental Biology|September 8, 2005
Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumorsHåkan Axelson, Erik Fredlund, Marie Ovenberger, et al.Plos One|March 30, 2011
GOBO: gene expression-based outcome for breast cancer onlineMarkus Ringnér, Erik Fredlund, Jari Häkkinen, et al.Breast Cancer Research : BCR|July 31, 2012
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transitionErik Fredlund, Johan Staaf, Juha K Rantala, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularizationRosa Noguera, Erik Fredlund, Marta Piqueras, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancerAnna-Maria Larsson, Karin Jirström, Erik Fredlund, et al.Pageof 4